|
Real-time Estimate
Cboe BZX
15:42:14 06/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 218.23 USD | -2.40% |
|
-3.59% | +24.39% |
| 10-02 | Biogen's experimental lupus drug shows benefit against skin symptoms | RE |
| 10-02 | Biogen Says Litifilimab Shows Efficacy in New 52-Week Phase 2 Data | MT |
Chart: Technical Analysis
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| BIIB | Delayed | |
CBOE
| BIIB | Real-time | |
|
Tradegate
| IDP | Real-time | |
|
Xetra
| IDP | Delayed | |
|
Boerse Muenchen
| IDP | Real-time | |
|
Mexican S.E.
| BIIB * | End-of-day quote | |
|
Borsa Italiana
| 1BIIB | End-of-day quote | |
|
Kazakhstan S.E.
| BIIB_KZ | End-of-day quote | |
|
Deutsche Boerse AG
| IDP | Delayed | |
|
Swiss Exchange
| BIIB | Delayed | |
|
Wiener Boerse
| BIIB | End-of-day quote | |
|
Börse Stuttgart
| IDP | Delayed | |
|
Santiago S.E.
| BIIB | End-of-day quote | |
|
Santiago S.E.
| BIIBCL | End-of-day quote | |
|
Swiss Exchange
| BIIB | Delayed | |
Sao Paulo
| BIIB34 | Delayed | |
Buenos Aires S.E.
| BIIB | End-of-day quote | |
|
Buenos Aires S.E.
| BIIBD | End-of-day quote |
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bullish | Bullish |
| Resistance | 228.69 | 228.69 | 227.6 |
| Spread/Res. | -4.28% | -4.28% | -3.82% |
| Spread/Supp. | -0.06% | +7.37% | +12.07% |
| Support | 219.05 | 203.89 | 195.34 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- BIIB Stock
- Charts Biogen Inc.
Select your edition
All financial news and data tailored to specific country editions
